Collection of online resources for prevention and control of antimicrobial resistance and healthcare-associated infections now available
ECDC gathered guidance documents on prevention and control of infection with carbapenem-resistant Enterobacteriaceae (CRE) available online, published by EU/EEA Member States, ECDC, other agencies and scientific societies.
Epidemiological update: invasive infections with Mycobacterium chimaera potentially associated with heater-cooler units used during cardiac surgery
On 21 May, Public Health England (PHE) reported that a retrospective investigation identified 13 patients with endocarditis, surgical site infection or disseminated infection with Mycobacterium chimaera or other Mycobacterium avium complex (MAC) species within four years of surgery involving cardiopulmorary bypass.
Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds – editorial in Eurosurveillance
The editorial published yesterday in Eurosurveillance highlights the current situation on the spread of plasmid-mediated colistin resistance gene (mcr-1). It also summarises available data from previously published articles and raises awareness about yet another threat to patient safety.
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Europe
The global rise of carbapenemase-producing Enterobacteriaceae (CPE) is alarming and is an increasing threat to patient safety, in Europe and globally.
Antimicrobial resistance remains high – says EU report
The findings in the latest report on antimicrobial resistance (AMR) in bacteria from ECDC and EFSA underline the serious threat AMR poses to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25 000 deaths in the EU every year.
Survey on antimicrobial resistance in intensive care units currently open
Antibiotic resistance is a threat to public health. It compromises the treatment of infected patients, in particular that of the most severely ill patients. Increasingly, intensive care physicians in Europe are confronted with infections caused by bacteria for which limited or no adequate treatment options are available.
Emerging spread of new fungal species poses risk for healthcare settings in the EU/EEA
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.
Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 found in travellers previously hospitalised in Gran Canaria, Spain
Thirteen patients with OXA-48-producing Klebsiella pneumoniae ST392 have been reported by Sweden and Norway between January and April 2018 - all returning travellers with prior hospital admission in Gran Canaria. Whole genome sequencing showed tight clustering between the bacterial isolates from the cases.
One Health to Keep Antibiotics Working
For EAAD 2018 ECDC will host the event “One Health to Keep Antibiotics Working” where ECDC will present the latest estimates of the health burden of antibiotic resistance, and the new data on the prevalence of healthcare-associated infections and of antimicrobial consumption in acute care hospitals and long-term care facilities in the EU/EEA.
ECDC calls for continued action to address antimicrobial resistance in healthcare settings
On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.